Antibiotics for duration of symptomsAntibiotics for duration of prescribed course
Antibiotics for duration of symptoms: Antibiotics for duration of child's symptoms
Antibiotics for duration of prescribed course: Antibiotics for the duration of the prescribed course
Study summary
The aim of the StopStop@HITH study is to see if stopping antibiotics when symptoms stop is as good as finishing the course of antibiotics. The study will enrol children at the Royal Children's Hospital who are prescribed oral antibiotics after completing a course of intravenous (IV) antibiotics for the treatment of cellulitis, urinary tract infection (UTI), lower respiratory tract infection (LRTI) and lymphadenitis.
The aims of the study are:
* To determine if oral antibiotics can be safely stopped once symptoms stop in children with cellulitis (who have completed a course of IV antibiotics).
* To assess feasibility of a larger study of other common infections across multiple hospitals.
The participants parent/guardian will complete a daily symptom tracker for the duration of the prescribed oral antibiotic course and attend a telehealth appointment with the study team once the participants symptoms have resolved. There are additional follow up surveys at day 14, day 28 and day 180.
Eligibility
Sex
ALL
Min age
1 Year
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria:
1. Between the ages of ≥ 1 years and ≤ 17 years at enrolment
2. Diagnosis of cellulitis, urinary tract infection (UTI), lower respiratory tract infection (LRTI) or lymphadenitis
3. Prescription of oral antibiotics as a switch from IV antibiotics
Exclusion Criteria:
1. Clinician determined need for \>10-day oral antibiotic course
2. Child with immunosuppression (e.g. as a result of cancer treatment)
3. Second episode of same bacterial infection within the last 28 days
4. Child is unable to take oral antibiotics
5. Previous enrolment in StopStop@HITH
6. Parent/guardian does not speak English
7. Clinician determined need for 10-day course of oral antibiotics for treatment/clearance of streptococcal infection
8. UTI only: known impaired renal function (e.g. renal transplant patients or known chronic renal failure)
9. LRTI only: known chronic respiratory condition (e.g. cystic fibrosis or bronchiectasis) or need for long term respiratory support (e.g. home oxygen, Continuous Positive Airway Pressure \[CPAP\] or tracheostomy); empyema or lung abscess
Primary outcome measure(s)
The proportion of children with clinical failure within 28 days of initial dose of antibiotics, defined as the requirement to restart antibiotics (either IV or oral) due to the reoccurrence of symptoms attributable to study condition [basket 1] — Day 14 & Day 28 The need to restart antibiotics will be assessed by a clinician independent of the study (e.g. General practitioner \[GP\], HITH or Emergency Department \[ED\] clinician). The need to restart antibiotics will be documented on the follow up study-specific survey via REDCap and will be completed by the parent/guardian at 14 and 28 days.
Trial sites (1)
Facility
City
Region
Status
Royal Children's Hospital
Melbourne
Victoria
Recruiting
More Murdoch Childrens Research Institute trials in Australia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.